X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3742) 3742
Book Review (655) 655
Publication (383) 383
Book / eBook (7) 7
Book Chapter (5) 5
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3687) 3687
index medicus (3536) 3536
male (1873) 1873
female (1819) 1819
hematology (1742) 1742
oncology (1734) 1734
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1628) 1628
child (1576) 1576
adolescent (1242) 1242
child, preschool (1132) 1132
cancer (1039) 1039
leukemia (976) 976
adult (894) 894
precursor cell lymphoblastic leukemia-lymphoma - genetics (887) 887
precursor cell lymphoblastic leukemia-lymphoma - pathology (838) 838
acute lymphocytic leukemia (817) 817
antineoplastic combined chemotherapy protocols - therapeutic use (815) 815
chemotherapy (807) 807
children (796) 796
infant (785) 785
acute lymphoblastic leukemia (771) 771
prognosis (724) 724
treatment outcome (700) 700
acute lymphoblastic-leukemia (628) 628
pediatrics (575) 575
middle aged (574) 574
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (551) 551
animals (540) 540
precursor cell lymphoblastic leukemia-lymphoma - therapy (516) 516
therapy (485) 485
research (476) 476
remission induction (458) 458
care and treatment (433) 433
minimal residual disease (424) 424
precursor cell lymphoblastic leukemia-lymphoma - mortality (424) 424
cell line, tumor (403) 403
mice (403) 403
antineoplastic agents - therapeutic use (399) 399
recurrence (395) 395
aged (378) 378
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (377) 377
genetic aspects (374) 374
risk factors (374) 374
acute myeloid-leukemia (370) 370
childhood (370) 370
apoptosis (368) 368
expression (351) 351
acute lymphatic leukemia (348) 348
young adult (348) 348
health aspects (344) 344
precursor cell lymphoblastic leukemia-lymphoma - metabolism (343) 343
abridged index medicus (331) 331
disease-free survival (312) 312
analysis (311) 311
precursor b-cell lymphoblastic leukemia-lymphoma - pathology (300) 300
transplantation (292) 292
article (291) 291
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (287) 287
acute lymphocytic-leukemia (272) 272
gene expression (266) 266
hematology, oncology and palliative medicine (259) 259
precursor cell lymphoblastic leukemia-lymphoma - immunology (253) 253
relapse (253) 253
immunophenotyping (250) 250
precursor cell lymphoblastic leukemia-lymphoma - complications (247) 247
apoptosis - drug effects (244) 244
flow cytometry (244) 244
retrospective studies (243) 243
antineoplastic agents - pharmacology (239) 239
t cells (238) 238
diagnosis (237) 237
survival (234) 234
follow-up studies (231) 231
lymphatic leukemia (228) 228
hemic and lymphatic diseases (225) 225
antineoplastic combined chemotherapy protocols - adverse effects (224) 224
survival analysis (224) 224
survival rate (223) 223
risk (219) 219
medicine & public health (215) 215
combined modality therapy (214) 214
mutation (214) 214
cell biology (213) 213
methotrexate - administration & dosage (212) 212
lymphoma (203) 203
bone marrow (202) 202
stem cells (199) 199
stem-cell transplantation (191) 191
vincristine - administration & dosage (191) 191
cells (189) 189
all (187) 187
antineoplastic combined chemotherapy protocols - administration & dosage (185) 185
philadelphia chromosome (181) 181
drug therapy (180) 180
immunology (174) 174
patients (169) 169
tumor cells, cultured (166) 166
hematopoietic stem cell transplantation (165) 165
physiological aspects (164) 164
lymphomas (163) 163
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3631) 3631
Chinese (46) 46
Japanese (22) 22
Spanish (14) 14
German (10) 10
French (8) 8
Russian (7) 7
Italian (3) 3
Polish (3) 3
Hungarian (2) 2
Korean (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2493 - 2498
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
About 25% of young adults with ALL have Ph-like genotypes, which are associated with poor outcomes with conventional treatment. In this gene-expression study,... 
MEDICINE, GENERAL & INTERNAL | MODELS | B-CELL PRECURSOR | INHIBITOR THERAPY | IMATINIB | PEDIATRIC ACUTE LEUKEMIAS | GENE FUSION | EXPRESSION | ETV6-NTRK3 FUSION TRANSCRIPTS | CRLF2 | DELETION | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Adolescence | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Cell lines | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2009, Volume 360, Issue 5, pp. 470 - 480
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 11, pp. 1044 - 1053
Journal Article
Blood, ISSN 0006-4971, 08/2011, Volume 118, Issue 8, pp. 2077 - 2084
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3880 - 3889
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2015, Volume 171, Issue 5, pp. 763 - 775
Obinutuzumab is a novel glycoengineered Type‐ II CD 20 monoclonal antibody. CD 20 is expressed in approximately 100% of children and adolescents with Burkitt... 
ALL | pre‐B | BL | rituximab‐sensitive | rituximab‐resistant | obinutuzumab | rituximab | Rituximab | Obinutuzumab | Pre-B-ALL | Rituximab-sensitive BL | Rituximab-resistant BL | pre-B-ALL | NATURAL-KILLER-CELLS | ONCOLOGY GROUP-REPORT | rituximab-sensitive BL | rituximab-resistant ill | PHASE I/II | CHEMOTHERAPY PLUS RITUXIMAB | CHILDREN | IN-VITRO | ANTI-CD20 MONOCLONAL-ANTIBODY | NON-HODGKIN-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA | HEMATOLOGY | Neoplasm Transplantation | Apoptosis - drug effects | Humans | Transplantation, Heterologous | Rituximab - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Caspases - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Survival Analysis | Cell Line, Tumor | Caspases - drug effects | Lysosomal-Associated Membrane Protein 1 - metabolism | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Killer Cells, Natural - drug effects | Mice | Interferon-gamma - biosynthesis | Molecular Targeted Therapy - methods | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Evaluation | Cell death | Patient outcomes | Monoclonal antibodies | Biochemistry | Comparative analysis | Antineoplastic agents | Burkitt's lymphoma | Index Medicus
Journal Article